A Study of the Natural Progression of Interstitial Lung Disease (ILD) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of the Natural Progression of Interstitial Lung Disease (ILD) — Stella

Home/Interstitial Lung Diseases/

View on ClinicalTrials.gov

Recruiting

Back to Interstitial Lung Diseases trials

Trial locations(1 site)

United States

University of Chicago, Chicago, Illinois

Key details

Sponsor

University of Chicago

Collaborators

Idiopathic Pulmonary Fibrosis Clinical Research Network, National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment target

~4,000 participants

Started

September 2005

Primary completion

December 2030

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.